US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Senti Biosciences, Inc.

3.84

+0.28007.87%

Post-market: 3.69-0.1500-3.91%19:47 EDT

Volume:67.61K

Turnover:248.27K

Market Cap:100.15M

PE:-0.40

High:3.88

Open:3.57

Low:3.30

Close:3.56

Loading ...

Overview Company News Filings

Senti Biosciences Initiated at Buy by Laidlaw & Co.

Senti Bio initiated with a Buy at Laidlaw

Press Release: Senti Bio Receives Additional $1.0 Million Tranche from California Institute for Regenerative Medicines (CIRM) Grant for Advancing Clinical Development of SENTI-202

Senti Biosciences Inc. Reports Q1 2025 Financial Results: R&D Expenses Rise by $0.5M, Cash Holdings at $33.8M; Positive SENTI-202 Clinical Data Announced

Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY

BRIEF-Senti Biosciences Q1 Net Income USD -14.112 Million

Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive Senti-202 Clinical Development

THOMSON REUTERS

Senti Biosciences Q1 EPS USD -1.41

THOMSON REUTERS

Press Release: Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development

Senti Biosciences Is Maintained at Buy by Chardan Capital

Biotech Alert: Searches spiking for these stocks today

Senti Bio Releases Virtual Investor “What This Means” Segment

Senti Bio to Present at the Citizens JMP Life Sciences Conference

Top Midday Decliners

MT Newswires Live

Senti Biosciences Pauses Enrollment in Hepatocellular Carcinoma Trial in China; Shares Fall

Senti Bio's SENTI-202, A First-In-Class Off-The-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results In The Treatment Of Pati

Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML

Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 on Monday, April 28th at 8:30 AM ET

Senti Bio Participates in a Virtual Investor KOL Connect Segment

Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SNTI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNTI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNTI\",,,,,undefined,":{"symbol":"SNTI","market":"US","secType":"STK","nameCN":"Senti Biosciences, Inc.","latestPrice":3.84,"timestamp":1749240000000,"preClose":3.56,"halted":0,"volume":67607,"hourTrading":{"tag":"盘后","latestPrice":3.69,"preClose":3.84,"latestTime":"19:47 EDT","volume":1217,"amount":4410.6479,"timestamp":1749253655889},"delay":0,"floatShares":11832412,"shares":26081139,"eps":-9.621946,"marketStatus":"Market Closed","change":0.28,"latestTime":"06-06 16:00:00 EDT","open":3.57,"high":3.8844,"low":3.3,"amount":248265.7763728,"amplitude":0.164157,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.621946,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1622001600000,"exchange":"NASDAQ","adjPreClose":3.56,"preHourTrading":{"tag":"盘前","latestPrice":3.48,"preClose":3.56,"latestTime":"08:07 EDT","volume":20,"amount":69.6,"timestamp":1749211624226},"postHourTrading":{"tag":"盘后","latestPrice":3.69,"preClose":3.84,"latestTime":"19:47 EDT","volume":1217,"amount":4410.6479,"timestamp":1749253655889},"volumeRatio":3.5704025038579434},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNTI\",,,,,undefined,":{"symbol":"SNTI","floatShares":11832412,"roa":"-36.46%","roe":"-116.63%","lyrEps":-12.034954,"volumeRatio":3.5704025038579434,"shares":26081139,"dividePrice":0,"high":3.8844,"amplitude":0.164157,"preClose":3.56,"low":3.3,"week52Low":1.5201,"pbRate":"2.65","week52High":16.94,"institutionHeld":0,"latestPrice":3.84,"eps":-9.621946,"divideRate":0,"volume":67607,"delay":0,"ttmEps":-9.621946,"open":3.57,"prevYearClose":3.51,"prevWeekClose":3.14,"prevMonthClose":3.14,"prevQuarterClose":3.36,"fiveDayClose":3.14,"twentyDayClose":3.31,"sixtyDayClose":3.34},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNTI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541502298","title":"Senti Biosciences Initiated at Buy by Laidlaw & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2541502298","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541502298?lang=en_us&edition=fundamental","pubTime":"2025-06-06 21:02","pubTimestamp":1749214920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SNTI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 06, 2025 09:02 ET (13:02 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4139","BK4539"],"gpt_icon":0},{"id":"2541483244","title":"Senti Bio initiated with a Buy at Laidlaw","url":"https://stock-news.laohu8.com/highlight/detail?id=2541483244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541483244?lang=en_us&edition=fundamental","pubTime":"2025-06-06 17:00","pubTimestamp":1749200430,"startTime":"0","endTime":"0","summary":"Laidlaw initiated coverage of Senti Bio (SNTI) with a Buy rating and $5 price target Senti is an early clinical stage oncology-emphasized biotech c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/senti-bio-initiated-with-a-buy-at-laidlaw-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/senti-bio-initiated-with-a-buy-at-laidlaw-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2537494642","title":"Press Release: Senti Bio Receives Additional $1.0 Million Tranche from California Institute for Regenerative Medicines (CIRM) Grant for Advancing Clinical Development of SENTI-202","url":"https://stock-news.laohu8.com/highlight/detail?id=2537494642","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537494642?lang=en_us&edition=fundamental","pubTime":"2025-05-22 20:30","pubTimestamp":1747917000,"startTime":"0","endTime":"0","summary":"\"We are grateful for the continued support of the CIRM as we continue to rapidly enroll into our SENTI-202 clinical trial. We are committed to advancing this important program forward and based on the recently presented positive preliminary results, we are becoming more confident in its potential to provide a much-needed treatment option for patients, \" commented Timothy Lu, MD, PhD, Co-Founder and CEO of Senti Biosciences.SENTI-202 is the Company's first-in-class off-the-shelf Logic Gated CD33 OR FLT3 NOT EMCN CAR NK cell therapy product candidate designed to selectively target and eliminate CD33 and/or FLT3-expressing hematologic malignancies, such as AML and myelodysplastic syndrome , while sparing healthy bone marrow cells. SENTI-202 is currently being evaluated in a Phase 1 clinical trial .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCO","SNTI","BK4539"],"gpt_icon":0},{"id":"2533979695","title":"Senti Biosciences Inc. Reports Q1 2025 Financial Results: R&D Expenses Rise by $0.5M, Cash Holdings at $33.8M; Positive SENTI-202 Clinical Data Announced","url":"https://stock-news.laohu8.com/highlight/detail?id=2533979695","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533979695?lang=en_us&edition=fundamental","pubTime":"2025-05-07 05:40","pubTimestamp":1746567625,"startTime":"0","endTime":"0","summary":"Senti Biosciences Inc. Reports Q1 2025 Financial Results: R&D Expenses Rise by $0.5M, Cash Holdings at $33.8M; Positive SENTI-202 Clinical Data Announced. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senti Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nNDL3xF6D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Senti Biosciences Inc. Reports Q1 2025 Financial Results: R&D Expenses Rise by $0.5M, Cash Holdings at $33.8M; Positive SENTI-202 Clinical Data Announced","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2533617660","title":"Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2533617660","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533617660?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:54","pubTimestamp":1746564892,"startTime":"0","endTime":"0","summary":"Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45237834/senti-biosciences-q1-eps-1-41-up-from-2-60-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI"],"gpt_icon":0},{"id":"2533667390","title":"BRIEF-Senti Biosciences Q1 Net Income USD -14.112 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533667390","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533667390?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:35","pubTimestamp":1746563745,"startTime":"0","endTime":"0","summary":"BRIEF-Senti Biosciences Q1 Net Income USD -14.112 Million\n\n\nMay 06 (Reuters) - Senti Biosciences Q1 EPS USD -1.41.\n\nQ1 operating expenses USD 16.397 million\nQ1 operating income USD -16.397 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nPLX2AE628:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2533966733","title":"Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive Senti-202 Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2533966733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533966733?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:35","pubTimestamp":1746563700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nTUA2NMC4S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2533667334","title":"Senti Biosciences Q1 EPS USD -1.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2533667334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533667334?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:35","pubTimestamp":1746563700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nPLX2AE628:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNTI","BK4139","BK4539"],"gpt_icon":0},{"id":"2533667539","title":"Press Release: Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2533667539","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533667539?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:35","pubTimestamp":1746563700,"startTime":"0","endTime":"0","summary":"Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development. Positive Phase 1 data from lead program, SENTI-202, recently presented at the AACR Annual Meeting:. SENTI-202 was generally well tolerated, preliminary RP2D identified;4 of 7 patients achieved composite Complete Remission  , all 4 cCR patients were measurable residual disease  negative as assessed by local standard of care;All cCR patients maintaining responses, from 4+ to 8+ months ongoing. Ongoing enrollment in Phase 1 SENTI-202 study to confirm the preliminary recommended Phase 2 dose  followed by disease specific expansion cohorts. Logic-Gated cell therapy approach may have the potential for broad liquid and solid tumor applications, providing multiple pipeline expansion opportunities. As previously announced, SENTI-202 was well-tolerated with no dose limiting toxicities and a maximum tolerated dose was not reached. The preliminary recommended Phase 2 d","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CCS","SNTI","BK4088"],"gpt_icon":0},{"id":"2532561846","title":"Senti Biosciences Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2532561846","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532561846?lang=en_us&edition=fundamental","pubTime":"2025-05-02 20:50","pubTimestamp":1746190200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SNTI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 02, 2025 08:50 ET (12:50 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI"],"gpt_icon":0},{"id":"2532000582","title":"Biotech Alert: Searches spiking for these stocks today","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000582","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532000582?lang=en_us&edition=fundamental","pubTime":"2025-05-02 00:15","pubTimestamp":1746116123,"startTime":"0","endTime":"0","summary":"These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:. Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter.Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.Tevogen Bio Holdings , 332% surge in interest. Pipeline and key clinical candidates for these companies:. Galmed is a clinical stage biopharmaceutical company focused on the development of Aramchol for liver and fibro-inflammatory diseases. The company has focused almost exclusively on developing Aramchol for the treatment of noncirrhotic nonalcoholic steatohepatitis, or NASH, and are currently developing Aramchol for Primary Sclerosing Cholangitis, or PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of liver disease.CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161523387.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-alert-searches-spiking-stocks-161523387.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0070302665.USD","BK4532","TVGN","BK4007","RGLS","CMMB","BK4139","CGON","LU0211331839.USD","IE00B4R5TH58.HKD","BCDA","IE0002141913.USD","BK4578","IE0009355771.USD","IE00B2B36J28.USD","BCDAW","BK4585","LU0320765489.SGD","MKKGY","BK4588","SNTI","IE00BJJMRZ35.SGD","LU0208291251.USD","NVS","IE00BJT1NW94.SGD","SWTX","IE00BFTCPJ56.SGD","BK4539","TVGNW","GLMD"],"gpt_icon":0},{"id":"2532089280","title":"Senti Bio Releases Virtual Investor “What This Means” Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2532089280","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532089280?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:15","pubTimestamp":1746105300,"startTime":"0","endTime":"0","summary":"Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio discusses the positive data from lead program, SENTI-202, recently presented at the American Association for Cancer Research  Annual Meeting 2025. SOUTH SAN FRANCISCO, Calif., May 01, 2025  -- Senti Biosciences, Inc.  , a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer participated in a Virtual Investor “What This Means” segment.The Virtual Investor “What This Means” segment featuring Senti Bio is now available here.Senti Bio has published SENTI-202 preclinical data demonstrating the potential of Logic Gated CAR-NK cell therapy for the treatment of AML.AML is a cancer of the blood and bone marrow and is the most common type of acute leuk","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/senti-bio-releases-virtual-investor-131500065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4539","SNTI"],"gpt_icon":0},{"id":"2531444030","title":"Senti Bio to Present at the Citizens JMP Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531444030","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531444030?lang=en_us&edition=fundamental","pubTime":"2025-04-30 21:00","pubTimestamp":1746018000,"startTime":"0","endTime":"0","summary":"Live video webcast presentation on Thursday, May 8th at 1:00 PM ET. SOUTH SAN FRANCISCO, Calif., April 30, 2025  -- Senti Biosciences, Inc.  , a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced Timothy Lu, MD, PhD, Co-Founder and CEO of Senti Biosciences will present on Thursday, May 8, 2025 at 1:00 PM ET at the Citizens JMP Life Sciences Conference being held in New York, NY.In addition to the presentation, management will be available to participate in one-on-one in-person meetings with qualified members of the investor community who are registered to attend the conference.A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website  and will be accessible for 90 days following the live event.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/senti-bio-present-citizens-jmp-130000122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNTI","BK4539","BK4139","JMP","BK4127"],"gpt_icon":0},{"id":"2531255249","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2531255249","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531255249?lang=en_us&edition=fundamental","pubTime":"2025-04-29 01:54","pubTimestamp":1745862845,"startTime":"0","endTime":"0","summary":"Senti Biosciences  said Monday enrollment in the investigator-sponsored trial for SENTI-301A, a treatment for hepatocellular carcinoma, has been paused.Shares slumped 22% as intraday trading volume rose to over 3.4 million from a daily average of about 30,000.Morgan Stanley downgraded Adecoagro's  shares to underweight from equal-weight while adjusting the stock's price target to $10 from $13.Last week, BofA Securities cut the company's shares to underperform from neutral.Shares of Adecoagro retreated 9% as intraday trading volume climbed to more than 1 million from a daily average of roughly 941,000.Baird downgraded the shares of Custom Truck One Source  to neutral from outperform while adjusting its price target to $5 from $6.Shares of Custom Truck dropped 8%, with intraday trading volume at over 364,000 versus the stock's daily average of about 790,000.Price: 3.89, Change: -1.11, Percent Change: -22.20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4104","LU1074936037.SGD","LU0098860793.USD","LU2271345857.HKD","LU1668664300.SGD","LU2089283258.USD","LU2133065610.SGD","LU0314104364.USD","LU0106831901.USD","LU1720051017.SGD","LU2089284900.SGD","LU1732799900.SGD","LU1989772923.USD","BK4539","BK4212","LU2347655156.SGD","LU0267386448.USD","LU1162221912.USD","LU2023251221.USD","IE00BKVL7J92.USD","LU0158827948.USD","LU2357305700.SGD","BK4585","LU0912757837.SGD","LU1548497426.USD","LU2111349929.HKD","LU1720051108.HKD","LU1732800096.USD","BK4534","LU0106261372.USD","BK4127","LU1363072403.SGD","CTOS","LU2028103732.USD","AGRO","BK4504","BK4139","LU0971096721.USD","LU1989772840.SGD","LU0320765646.SGD","LU0158827781.USD","LU0795875086.SGD","BK4516","BK4581","LU0006306889.USD","IE00BZ1G4Q59.USD","BK4588","LU0225283273.USD","SNTI","LU0795875169.SGD"],"gpt_icon":0},{"id":"2531258095","title":"Senti Biosciences Pauses Enrollment in Hepatocellular Carcinoma Trial in China; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2531258095","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531258095?lang=en_us&edition=fundamental","pubTime":"2025-04-29 00:36","pubTimestamp":1745858210,"startTime":"0","endTime":"0","summary":"Senti Biosciences  said Monday enrollment in the investigator-sponsored trial for SENTI-301A, a treatment for hepatocellular carcinoma, has been paused.The study is being conducted in partnership with Celest Therapeutics  Co. in China and uses Senti's SENTI-301A gene circuit in Chimeric Antigen Receptor Natural Killer cells manufactured by Celest. The trial was halted after dose-limiting toxicities were observed. Senti Bio is currently evaluating next steps for the program as part of a broader pipeline prioritization effort, the company said.The company also reported additional preliminary data from its phase 1 trial of SENTI-202, an investigational off-the-shelf CAR-NK cell therapy that is being developed for the treatment of relapsed or refractory hematologic cancers, including acute myeloid leukemia.In the dose-finding stage, SENTI-202 was well tolerated, with no dose-limiting toxicities reported and no maximum tolerated dose reached, and a preliminary recommended phase 2 dose was i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/senti-biosciences-pauses-enrollment-hepatocellular-163650067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4539","SNTI"],"gpt_icon":0},{"id":"2530477789","title":"Senti Bio's SENTI-202, A First-In-Class Off-The-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results In The Treatment Of Pati","url":"https://stock-news.laohu8.com/highlight/detail?id=2530477789","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530477789?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:38","pubTimestamp":1745840295,"startTime":"0","endTime":"0","summary":"April 28 (Reuters) - Senti Biosciences Inc ::*SENTI BIO’S SENTI-202, A FIRST-IN-CLASS OFF-THE-SHELF LOGIC GATED SELECTIVE CD33 OR FLT3 NOT EMCN CAR NK CELL THERAPY, DEMONSTRATES POSITIVE PRELIMINARY C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nRSD41G2QR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SNTI","BK4139"],"gpt_icon":0},{"id":"2530365288","title":"Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML","url":"https://stock-news.laohu8.com/highlight/detail?id=2530365288","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530365288?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:00","pubTimestamp":1745838000,"startTime":"0","endTime":"0","summary":"Data presented at the American Association for Cancer Research  Annual Meeting 2025. Dose Finding completed with no dose limiting toxicities and preliminary recommended Phase 2 dose  identified. 5 of 7 best overall response evaluable patients achieved ORR  across all dose cohorts, including 1 CR and 1 CRh in 3 patients in preliminary RP2D cohort. 4 of 4 cCR patients were measurable residual disease  negative as assessed by local standard of care. Early deep responses with SENTI-202 noted across dose levels with all cCRs ongoing as of the data cut and longest durability of 8+ months. Company to host webcast to discuss the new Phase 1 SENTI-202 data today, April 28th at 8:30 AM ET; Register Here. Announces certain preliminary first quarter 2025 financial results and provides pipeline update. The Phase 1 study evaluated two dose levels  and two schedules  of SENTI-202 administered every 28 days on Days 0,7,14 or Days 0,3,7,10,14, respective","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/senti-bio-senti-202-first-110000851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","OR","BK4139","BK4017","BK4022","SNTI","BK4539","BK4230","BK4218","PK","CAR"],"gpt_icon":0},{"id":"2529932895","title":"Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 on Monday, April 28th at 8:30 AM ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2529932895","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529932895?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:35","pubTimestamp":1745498100,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., April 24, 2025  -- Senti Biosciences, Inc.  , a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it will host a conference call and webcast to discuss the new SENTI-202 Phase 1 clinical data being presented at the American Association for Cancer Research  Annual Meeting on Monday, April 28, 2025 at 8:30 AM ET.The call will be hosted by Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder, and Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer, of Senti Bio. Interested participants and investors may access the conference call by dialing  524-8416  or +1  902-1028 . The webcast will be accessible on the Events page under the Investors section of the Company’s website  and will be archived for 90 days following the live event.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/senti-bio-host-conference-call-123500425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4218","BK4585","ET","BK4117","BK4107","BK4561","BK4581","HST","SNTI","BK4588","BK4539","AFG","BK4181","AM","BK4590","BK4144"],"gpt_icon":0},{"id":"2529077948","title":"Senti Bio Participates in a Virtual Investor KOL Connect Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2529077948","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529077948?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:05","pubTimestamp":1745240700,"startTime":"0","endTime":"0","summary":"Moderated discussion with Stephen Strickland, MD, MSCI, internationally respected leukemia researcher, Director of Leukemia Research for Sarah Cannon Research Institute and Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio. SOUTH SAN FRANCISCO, Calif., April 21, 2025  -- Senti Biosciences, Inc.  , a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced the release of a Virtual Investor KOL segment featuring Stephen Strickland, MD, MSCI, leukemia researcher, Director of Leukemia Research for Sarah Cannon Research Institute .As part of the segment, Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio and Dr. Strickland discussed acute myeloid leukemia , the current treatment landscape and areas of unmet need, highlighting Senti Bio’s lead program, SENTI-202, and the clinical and preclinical data released by Senti to date.The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/senti-bio-participates-virtual-investor-130500129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KOL","BK4139","SNTI","BK4539"],"gpt_icon":0},{"id":"2527243056","title":"Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2527243056","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527243056?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:15","pubTimestamp":1744809300,"startTime":"0","endTime":"0","summary":"Live moderated webcast with members of the Senti Bio management team on Wednesday, April 23rd at 4:00 PM ET. SOUTH SAN FRANCISCO, Calif., April 16, 2025  -- Senti Biosciences, Inc.  , a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that will participate in the Virtual Investor Closing Bell Series on Wednesday, April 23, 2025 at 4:00 PM ET.As part of the event, Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder, and Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer, of Senti Bio will provide a corporate overview. In addition to the moderated discussion, there will be a live question and answer session. The Company will answer as many questions as possible in the time allowed.A live video webcast of the presentation will be available on the Events page under the Investors section of the Company’s website . A webcast replay will be available two hours fol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/senti-bio-nasdaq-snti-participate-131500666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4139","LU2210150020.SGD","NVIW.SI","IE00B64PRP62.GBP","BK4585","QLD","MNQmain","USAW.SI","USJW.SI","IE00BGHQF748.EUR","LU2210149790.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","SNTI","NQmain","NDAQ",".IXIC","QID","TQQQ","TSYW.SI","IE00BKPKM429.USD","PSQ","BK4588","BK4112","SQQQ"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNTI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"SNTI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-1.41},{"market":"US","date":"2025-03-20","symbol":"SNTI","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2024-11-14","symbol":"SNTI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-6.31},{"market":"US","date":"2024-08-13","symbol":"SNTI","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-2.45},{"market":"US","date":"2024-07-18","symbol":"SNTI","defaultRemindTime":1721309400000,"type":"split","dateTimestamp":1721275200000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNTI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNTI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1733198400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNTI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNTI","date":"2025-06-06","current":-1.6946,"percent":0.395538,"low":-14.261319,"twenty":-6.405318,"median":-1.214806,"eighty":-0.249483,"high":-0.112174,"avg":-3.629317,"sd":5.03453,"marketCap":92848854},"quantilePoints":[{"date":"2021-05-28","current":-13.544217,"twenty":-13.001281,"median":-12.186878,"eighty":-12.135948,"marketCap":286555000},{"date":"2021-06-04","current":-13.544217,"twenty":-13.541508,"median":-13.530673,"eighty":-12.450219,"marketCap":286555000},{"date":"2021-06-11","current":-13.530673,"twenty":-13.541508,"median":-13.530673,"eighty":-13.481914,"marketCap":286268445},{"date":"2021-06-18","current":-13.517129,"twenty":-13.541508,"median":-13.517129,"eighty":-13.479205,"marketCap":285981890},{"date":"2021-06-25","current":-13.476496,"twenty":-13.541508,"median":-13.503584,"eighty":-13.465661,"marketCap":285122225},{"date":"2021-07-02","current":-13.857434,"twenty":-13.544217,"median":-13.503584,"eighty":-13.462952,"marketCap":293181725},{"date":"2021-07-09","current":-13.843507,"twenty":-13.544217,"median":-13.517129,"eighty":-13.462952,"marketCap":292887070},{"date":"2021-07-16","current":-13.704236,"twenty":-13.718163,"median":-13.530673,"eighty":-13.476496,"marketCap":289940520},{"date":"2021-07-23","current":-13.759944,"twenty":-13.787798,"median":-13.544217,"eighty":-13.476496,"marketCap":291119140},{"date":"2021-07-30","current":-13.704236,"twenty":-13.759944,"median":-13.544217,"eighty":-13.476496,"marketCap":289940520},{"date":"2021-08-06","current":-13.627637,"twenty":-13.73209,"median":-13.544217,"eighty":-13.49004,"marketCap":288319917},{"date":"2021-08-13","current":-13.578892,"twenty":-13.718163,"median":-13.547628,"eighty":-13.503584,"marketCap":287288625},{"date":"2021-08-20","current":-13.551038,"twenty":-13.704236,"median":-13.544217,"eighty":-13.49004,"marketCap":286699315},{"date":"2021-08-27","current":-13.843507,"twenty":-13.718163,"median":-13.564965,"eighty":-13.503584,"marketCap":292887070},{"date":"2021-09-03","current":-13.787798,"twenty":-13.787798,"median":-13.592819,"eighty":-13.503584,"marketCap":291708450},{"date":"2021-09-10","current":-13.801725,"twenty":-13.790583,"median":-13.592819,"eighty":-13.503584,"marketCap":292003105},{"date":"2021-09-17","current":-13.857434,"twenty":-13.815653,"median":-13.606746,"eighty":-13.508122,"marketCap":293181725},{"date":"2021-09-24","current":-13.718163,"twenty":-13.815653,"median":-13.627637,"eighty":-13.515555,"marketCap":290235175},{"date":"2021-10-01","current":-13.759944,"twenty":-13.815653,"median":-13.648528,"eighty":-13.517129,"marketCap":291119140},{"date":"2021-10-08","current":-13.801725,"twenty":-13.815653,"median":-13.690309,"eighty":-13.521973,"marketCap":292003105},{"date":"2021-10-15","current":-13.857434,"twenty":-13.815653,"median":-13.704236,"eighty":-13.529175,"marketCap":293181725},{"date":"2021-10-22","current":-13.871361,"twenty":-13.82958,"median":-13.718163,"eighty":-13.530673,"marketCap":293476380},{"date":"2021-10-29","current":-14.052413,"twenty":-13.843507,"median":-13.73209,"eighty":-13.530673,"marketCap":297306895},{"date":"2021-11-05","current":-13.982777,"twenty":-13.857434,"median":-13.746017,"eighty":-13.530673,"marketCap":295833620},{"date":"2021-11-12","current":-13.913142,"twenty":-13.871361,"median":-13.759944,"eighty":-13.535823,"marketCap":294360345},{"date":"2021-11-19","current":-13.927069,"twenty":-13.899215,"median":-13.759944,"eighty":-13.537111,"marketCap":294655000},{"date":"2021-11-26","current":-13.899215,"twenty":-13.899215,"median":-13.773871,"eighty":-13.541375,"marketCap":294065690},{"date":"2021-12-03","current":-13.787798,"twenty":-13.899215,"median":-13.773871,"eighty":-13.544217,"marketCap":291708450},{"date":"2021-12-10","current":-13.773871,"twenty":-13.899215,"median":-13.773871,"eighty":-13.544217,"marketCap":291413795},{"date":"2021-12-17","current":-13.982777,"twenty":-13.899215,"median":-13.787798,"eighty":-13.544217,"marketCap":295833620},{"date":"2021-12-23","current":-13.718163,"twenty":-13.899215,"median":-13.780835,"eighty":-13.544217,"marketCap":290235175},{"date":"2021-12-31","current":-13.73209,"twenty":-13.899215,"median":-13.773871,"eighty":-13.546945,"marketCap":290529830},{"date":"2022-01-07","current":-13.718163,"twenty":-13.899215,"median":-13.773871,"eighty":-13.551038,"marketCap":290235175},{"date":"2022-01-14","current":-13.718163,"twenty":-13.899215,"median":-13.766908,"eighty":-13.56218,"marketCap":290235175},{"date":"2022-01-21","current":-13.704236,"twenty":-13.893644,"median":-13.759944,"eighty":-13.578892,"marketCap":289940520},{"date":"2022-01-28","current":-13.73209,"twenty":-13.871361,"median":-13.759944,"eighty":-13.581677,"marketCap":290529830},{"date":"2022-02-04","current":-13.718163,"twenty":-13.868576,"median":-13.759944,"eighty":-13.592819,"marketCap":290235175},{"date":"2022-02-11","current":-13.746017,"twenty":-13.857434,"median":-13.746017,"eighty":-13.592819,"marketCap":290824485},{"date":"2022-02-18","current":-6.405966,"twenty":-13.857434,"median":-13.746017,"eighty":-13.556609,"marketCap":291413795},{"date":"2022-02-25","current":-6.412443,"twenty":-13.857434,"median":-13.746017,"eighty":-13.544217,"marketCap":291708450},{"date":"2022-03-04","current":-6.405966,"twenty":-13.857434,"median":-13.73209,"eighty":-13.537111,"marketCap":291413795},{"date":"2022-03-11","current":-6.399489,"twenty":-13.857434,"median":-13.73209,"eighty":-13.530673,"marketCap":291119140},{"date":"2022-03-18","current":-6.380057,"twenty":-13.843507,"median":-13.73209,"eighty":-13.517129,"marketCap":290235175},{"date":"2022-03-25","current":-6.412443,"twenty":-13.843507,"median":-13.73209,"eighty":-13.503584,"marketCap":291708450},{"date":"2022-04-01","current":-5.267879,"twenty":-13.843507,"median":-13.718163,"eighty":-13.476496,"marketCap":291413795},{"date":"2022-04-08","current":-5.257226,"twenty":-13.843507,"median":-13.718163,"eighty":-13.462952,"marketCap":290824485},{"date":"2022-04-14","current":-5.294511,"twenty":-13.843507,"median":-13.718163,"eighty":-13.175231,"marketCap":292887070},{"date":"2022-04-22","current":-5.257226,"twenty":-13.843507,"median":-13.718163,"eighty":-6.442238,"marketCap":290824485},{"date":"2022-04-29","current":-5.273205,"twenty":-13.843507,"median":-13.718163,"eighty":-6.412443,"marketCap":291708450},{"date":"2022-05-06","current":-5.270542,"twenty":-13.843507,"median":-13.718163,"eighty":-6.405966,"marketCap":291561122},{"date":"2022-05-13","current":-5.267879,"twenty":-13.832365,"median":-13.718163,"eighty":-6.405966,"marketCap":291413795},{"date":"2022-05-20","current":-5.299838,"twenty":-13.82958,"median":-13.704236,"eighty":-6.399489,"marketCap":293181725},{"date":"2022-05-27","current":-5.294511,"twenty":-13.82958,"median":-13.704236,"eighty":-6.398841,"marketCap":292887070},{"date":"2022-06-03","current":-4.697947,"twenty":-13.82958,"median":-13.704236,"eighty":-6.393011,"marketCap":259885710},{"date":"2022-06-10","current":-3.788101,"twenty":-13.82958,"median":-13.690309,"eighty":-6.393011,"marketCap":209553969},{"date":"2022-06-17","current":-2.063359,"twenty":-13.821224,"median":-13.676382,"eighty":-6.198754,"marketCap":95172427},{"date":"2022-06-24","current":-2.034964,"twenty":-13.815653,"median":-13.648528,"eighty":-5.311556,"marketCap":93862715},{"date":"2022-07-01","current":-1.807805,"twenty":-13.815653,"median":-13.624156,"eighty":-5.296642,"marketCap":83385017},{"date":"2022-07-08","current":-1.864595,"twenty":-13.815653,"median":-13.61371,"eighty":-5.294511,"marketCap":86004441},{"date":"2022-07-15","current":-1.703691,"twenty":-13.815653,"median":-13.598394,"eighty":-5.294511,"marketCap":78582738},{"date":"2022-07-22","current":-1.76048,"twenty":-13.815653,"median":-13.592819,"eighty":-5.283858,"marketCap":81202163},{"date":"2022-07-29","current":-2.962529,"twenty":-13.812867,"median":-13.578892,"eighty":-5.27427,"marketCap":136646651},{"date":"2022-08-05","current":-2.262123,"twenty":-13.801725,"median":-13.547628,"eighty":-5.271075,"marketCap":104340414},{"date":"2022-08-12","current":-1.997104,"twenty":-13.801725,"median":-13.544217,"eighty":-5.267879,"marketCap":92116432},{"date":"2022-08-19","current":-1.824017,"twenty":-13.801725,"median":-13.540664,"eighty":-5.267879,"marketCap":83302848},{"date":"2022-08-26","current":-1.871517,"twenty":-13.801725,"median":-13.530673,"eighty":-5.257226,"marketCap":85472193},{"date":"2022-09-02","current":-1.875831,"twenty":-13.79894,"median":-13.530673,"eighty":-5.252965,"marketCap":85669193},{"date":"2022-09-09","current":-1.990095,"twenty":-13.787798,"median":-13.520157,"eighty":-4.697947,"marketCap":90887621},{"date":"2022-09-16","current":-1.523517,"twenty":-13.787798,"median":-13.509257,"eighty":-2.962529,"marketCap":69579040},{"date":"2022-09-23","current":-1.266424,"twenty":-13.787798,"median":-13.503584,"eighty":-2.195868,"marketCap":57837577},{"date":"2022-09-30","current":-2.06627,"twenty":-13.787798,"median":-13.476496,"eighty":-2.167473,"marketCap":94366573},{"date":"2022-10-07","current":-4.265849,"twenty":-13.787798,"median":-13.471986,"eighty":-2.171012,"marketCap":194821312},{"date":"2022-10-14","current":-3.113689,"twenty":-13.787798,"median":-13.462952,"eighty":-2.176938,"marketCap":142202163},{"date":"2022-10-21","current":-2.180534,"twenty":-13.787798,"median":-13.444706,"eighty":-2.180534,"marketCap":99585001},{"date":"2022-10-28","current":-2.199578,"twenty":-13.787798,"median":-12.186878,"eighty":-2.180534,"marketCap":100454739},{"date":"2022-11-04","current":-2.237666,"twenty":-13.787798,"median":-6.448068,"eighty":-2.195868,"marketCap":102194215},{"date":"2022-11-11","current":-2.102217,"twenty":-13.787798,"median":-6.41892,"eighty":-2.180534,"marketCap":107011267},{"date":"2022-11-18","current":-1.947136,"twenty":-13.787798,"median":-6.412443,"eighty":-2.16149,"marketCap":99116994},{"date":"2022-11-25","current":-2.07637,"twenty":-13.787798,"median":-6.412443,"eighty":-2.126481,"marketCap":105695555},{"date":"2022-12-02","current":-1.93852,"twenty":-13.776656,"median":-6.405966,"eighty":-2.090094,"marketCap":98678423},{"date":"2022-12-09","current":-1.731745,"twenty":-13.773871,"median":-6.405966,"eighty":-2.067458,"marketCap":88152724},{"date":"2022-12-16","current":-1.318194,"twenty":-13.773871,"median":-6.405966,"eighty":-2.05809,"marketCap":67101327},{"date":"2022-12-23","current":-1.154496,"twenty":-13.773871,"median":-6.399489,"eighty":-2.022227,"marketCap":58768483},{"date":"2022-12-30","current":-1.214806,"twenty":-13.773871,"median":-6.399489,"eighty":-1.9943,"marketCap":61838478},{"date":"2023-01-06","current":-1.361272,"twenty":-13.771086,"median":-6.39787,"eighty":-1.981598,"marketCap":69294181},{"date":"2023-01-13","current":-1.628357,"twenty":-13.764122,"median":-6.393011,"eighty":-1.959244,"marketCap":82889875},{"date":"2023-01-20","current":-1.499122,"twenty":-13.759944,"median":-6.393011,"eighty":-1.941679,"marketCap":76311313},{"date":"2023-01-27","current":-1.535911,"twenty":-13.759944,"median":-6.393011,"eighty":-1.938118,"marketCap":78184011},{"date":"2023-02-03","current":-1.533585,"twenty":-13.759944,"median":-6.393011,"eighty":-1.917984,"marketCap":78065597},{"date":"2023-02-10","current":-1.362478,"twenty":-13.759944,"median":-6.067566,"eighty":-1.900018,"marketCap":69355581},{"date":"2023-02-17","current":-1.40435,"twenty":-13.759944,"median":-5.321144,"eighty":-1.871517,"marketCap":71487035},{"date":"2023-02-24","current":-1.309578,"twenty":-13.759944,"median":-5.299838,"eighty":-1.862017,"marketCap":66662757},{"date":"2023-03-03","current":-1.171728,"twenty":-13.759944,"median":-5.297175,"eighty":-1.8362,"marketCap":59645624},{"date":"2023-03-10","current":-1.16742,"twenty":-13.746017,"median":-5.294511,"eighty":-1.817901,"marketCap":59426339},{"date":"2023-03-17","current":-1.042493,"twenty":-13.746017,"median":-5.294511,"eighty":-1.80067,"marketCap":53067063},{"date":"2023-03-24","current":-0.956051,"twenty":-13.746017,"median":-5.294511,"eighty":-1.76048,"marketCap":55651722},{"date":"2023-03-31","current":-0.895349,"twenty":-13.746017,"median":-5.286522,"eighty":-1.703691,"marketCap":52118280},{"date":"2023-04-06","current":-0.818182,"twenty":-13.746017,"median":-5.283858,"eighty":-1.702409,"marketCap":47626391},{"date":"2023-04-14","current":-0.811884,"twenty":-13.746017,"median":-5.278532,"eighty":-1.6791,"marketCap":47259796},{"date":"2023-04-21","current":-0.720908,"twenty":-13.740447,"median":-5.273205,"eighty":-1.65085,"marketCap":41964049},{"date":"2023-04-28","current":-0.736083,"twenty":-13.733483,"median":-5.270542,"eighty":-1.623188,"marketCap":42847409},{"date":"2023-05-05","current":-0.743671,"twenty":-13.73209,"median":-5.267879,"eighty":-1.578524,"marketCap":43289090},{"date":"2023-05-12","current":-0.671432,"twenty":-13.73209,"median":-5.267879,"eighty":-1.559432,"marketCap":43726353},{"date":"2023-05-19","current":-0.66465,"twenty":-13.73209,"median":-5.267879,"eighty":-1.535446,"marketCap":43284673},{"date":"2023-05-26","current":-0.644304,"twenty":-13.73209,"median":-5.262552,"eighty":-1.478445,"marketCap":41959632},{"date":"2023-06-02","current":-0.595676,"twenty":-13.73209,"median":-5.257226,"eighty":-1.44362,"marketCap":38792784},{"date":"2023-06-09","current":-0.684997,"twenty":-13.73209,"median":-5.257226,"eighty":-1.430197,"marketCap":44609714},{"date":"2023-06-16","current":-0.678214,"twenty":-13.73209,"median":-5.2519,"eighty":-1.380226,"marketCap":44168034},{"date":"2023-06-23","current":-0.678214,"twenty":-13.73209,"median":-4.987667,"eighty":-1.361272,"marketCap":44168034},{"date":"2023-06-30","current":-0.415949,"twenty":-13.73209,"median":-4.8943,"eighty":-1.330101,"marketCap":27088255},{"date":"2023-07-07","current":-0.440839,"twenty":-13.723734,"median":-4.548805,"eighty":-1.309578,"marketCap":28709222},{"date":"2023-07-14","current":-0.479498,"twenty":-13.718163,"median":-4.024639,"eighty":-1.292347,"marketCap":31226800},{"date":"2023-07-21","current":-0.5697,"twenty":-13.718163,"median":-3.589788,"eighty":-1.245822,"marketCap":37101148},{"date":"2023-07-28","current":-0.562918,"twenty":-13.718163,"median":-3.085123,"eighty":-1.2126,"marketCap":36659468},{"date":"2023-08-04","current":-0.652781,"twenty":-13.718163,"median":-2.962529,"eighty":-1.197575,"marketCap":42511732},{"date":"2023-08-11","current":-0.541893,"twenty":-13.718163,"median":-2.658056,"eighty":-1.185513,"marketCap":35290259},{"date":"2023-08-18","current":-0.403298,"twenty":-13.718163,"median":-2.532848,"eighty":-1.165697,"marketCap":29145915},{"date":"2023-08-25","current":-0.394483,"twenty":-13.718163,"median":-2.404301,"eighty":-1.120034,"marketCap":28508919},{"date":"2023-09-01","current":-0.400647,"twenty":-13.718163,"median":-2.342408,"eighty":-1.07954,"marketCap":28954370},{"date":"2023-09-08","current":-0.396949,"twenty":-13.718163,"median":-2.275754,"eighty":-0.96995,"marketCap":28687099},{"date":"2023-09-15","current":-0.278604,"twenty":-13.718163,"median":-2.249894,"eighty":-0.907489,"marketCap":20134424},{"date":"2023-09-22","current":-0.321134,"twenty":-13.718163,"median":-2.199578,"eighty":-0.880174,"marketCap":23208041},{"date":"2023-09-29","current":-0.277371,"twenty":-13.718163,"median":-2.180534,"eighty":-0.840718,"marketCap":20045333},{"date":"2023-10-06","current":-0.218938,"twenty":-13.718163,"median":-2.180534,"eighty":-0.814403,"marketCap":15822450},{"date":"2023-10-13","current":-0.196009,"twenty":-13.718163,"median":-2.169243,"eighty":-0.804297,"marketCap":14165369},{"date":"2023-10-20","current":-0.215733,"twenty":-13.718163,"median":-2.142446,"eighty":-0.764841,"marketCap":15590815},{"date":"2023-10-27","current":-0.180538,"twenty":-13.718163,"median":-2.13668,"eighty":-0.758771,"marketCap":13047284},{"date":"2023-11-03","current":-0.175668,"twenty":-13.718163,"median":-2.111183,"eighty":-0.744217,"marketCap":12695378},{"date":"2023-11-10","current":-0.332845,"twenty":-13.718163,"median":-2.091754,"eighty":-0.724732,"marketCap":24054400},{"date":"2023-11-17","current":-0.245733,"twenty":-13.707021,"median":-2.074597,"eighty":-0.684997,"marketCap":17336986},{"date":"2023-11-24","current":-0.22755,"twenty":-13.704236,"median":-2.067012,"eighty":-0.678214,"marketCap":16054085},{"date":"2023-12-01","current":-0.271557,"twenty":-13.704236,"median":-2.063359,"eighty":-0.671161,"marketCap":19158884},{"date":"2023-12-08","current":-0.259434,"twenty":-13.704236,"median":-2.044429,"eighty":-0.665016,"marketCap":18303616},{"date":"2023-12-15","current":-0.239862,"twenty":-13.704236,"median":-2.025499,"eighty":-0.659333,"marketCap":16922716},{"date":"2023-12-22","current":-0.277176,"twenty":-13.704236,"median":-2.000811,"eighty":-0.652211,"marketCap":19555336},{"date":"2023-12-29","current":-0.373146,"twenty":-13.701451,"median":-1.990095,"eighty":-0.644331,"marketCap":26326204},{"date":"2024-01-05","current":-0.410398,"twenty":-13.693094,"median":-1.981598,"eighty":-0.640289,"marketCap":28954370},{"date":"2024-01-12","current":-0.339935,"twenty":-13.690309,"median":-1.980573,"eighty":-0.62667,"marketCap":23983128},{"date":"2024-01-19","current":-0.263412,"twenty":-13.690309,"median":-1.959244,"eighty":-0.602363,"marketCap":18584251},{"date":"2024-01-26","current":-0.259182,"twenty":-13.690309,"median":-1.948457,"eighty":-0.587877,"marketCap":18285798},{"date":"2024-02-02","current":-0.288983,"twenty":-13.681953,"median":-1.940315,"eighty":-0.5697,"marketCap":20388331},{"date":"2024-02-09","current":-0.272125,"twenty":-13.65967,"median":-1.938269,"eighty":-0.523825,"marketCap":19198975},{"date":"2024-02-16","current":-0.268337,"twenty":-13.648528,"median":-1.921385,"eighty":-0.481125,"marketCap":18931704},{"date":"2024-02-23","current":-0.264233,"twenty":-13.642957,"median":-1.917726,"eighty":-0.471277,"marketCap":18642160},{"date":"2024-03-01","current":-0.271494,"twenty":-13.631815,"median":-1.900018,"eighty":-0.455489,"marketCap":19154429},{"date":"2024-03-08","current":-0.254131,"twenty":-13.624852,"median":-1.890517,"eighty":-0.437584,"marketCap":17929437},{"date":"2024-03-15","current":-0.230012,"twenty":-13.620674,"median":-1.871517,"eighty":-0.419139,"marketCap":16227811},{"date":"2024-03-22","current":-0.296749,"twenty":-13.615103,"median":-1.864595,"eighty":-0.412341,"marketCap":20936237},{"date":"2024-03-28","current":-0.251125,"twenty":-13.606746,"median":-1.859862,"eighty":-0.402866,"marketCap":17844458},{"date":"2024-04-05","current":-0.249837,"twenty":-13.605076,"median":-1.845665,"eighty":-0.395963,"marketCap":17752948},{"date":"2024-04-12","current":-0.237925,"twenty":-13.597279,"median":-1.824017,"eighty":-0.39325,"marketCap":16906480},{"date":"2024-04-19","current":-0.186734,"twenty":-13.592819,"median":-1.817585,"eighty":-0.38526,"marketCap":13268956},{"date":"2024-04-26","current":-0.179458,"twenty":-13.592819,"median":-1.80067,"eighty":-0.374985,"marketCap":12751924},{"date":"2024-05-03","current":-0.23741,"twenty":-13.590034,"median":-1.777116,"eighty":-0.347317,"marketCap":16869876},{"date":"2024-05-10","current":-0.238247,"twenty":-13.578892,"median":-1.76048,"eighty":-0.329223,"marketCap":16929357},{"date":"2024-05-17","current":-0.269786,"twenty":-13.573321,"median":-1.723129,"eighty":-0.320641,"marketCap":17386907},{"date":"2024-05-24","current":-0.249197,"twenty":-13.551038,"median":-1.703691,"eighty":-0.30507,"marketCap":16060012},{"date":"2024-05-31","current":-0.222219,"twenty":-13.551038,"median":-1.703691,"eighty":-0.296749,"marketCap":14321321},{"date":"2024-06-07","current":-0.205889,"twenty":-13.544217,"median":-1.687139,"eighty":-0.290625,"marketCap":13268956},{"date":"2024-06-14","current":-0.186862,"twenty":-13.544217,"median":-1.677674,"eighty":-0.288175,"marketCap":12042721},{"date":"2024-06-21","current":-0.174154,"twenty":-13.544217,"median":-1.655285,"eighty":-0.28242,"marketCap":11223706},{"date":"2024-06-28","current":-0.226478,"twenty":-13.544217,"median":-1.654204,"eighty":-0.278604,"marketCap":14595851},{"date":"2024-07-05","current":-0.230738,"twenty":-13.544217,"median":-1.632896,"eighty":-0.278313,"marketCap":14870381},{"date":"2024-07-12","current":-0.222503,"twenty":-13.544217,"median":-1.628357,"eighty":-0.277332,"marketCap":14339623},{"date":"2024-07-15","current":-0.227188,"twenty":-13.544217,"median":-1.615433,"eighty":-0.277176,"marketCap":14641606},{"date":"2024-08-02","current":-0.153352,"twenty":-13.542796,"median":-1.60251,"eighty":-0.277176,"marketCap":9883084},{"date":"2024-08-09","current":-0.129923,"twenty":-13.537111,"median":-1.57998,"eighty":-0.274019,"marketCap":8373168},{"date":"2024-08-16","current":-0.162582,"twenty":-13.535823,"median":-1.576663,"eighty":-0.272125,"marketCap":10477899},{"date":"2024-08-23","current":-0.215526,"twenty":-13.530673,"median":-1.559432,"eighty":-0.271264,"marketCap":12274869},{"date":"2024-08-30","current":-0.217882,"twenty":-13.530673,"median":-1.549696,"eighty":-0.269875,"marketCap":12409033},{"date":"2024-09-06","current":-0.237178,"twenty":-13.530673,"median":-1.533585,"eighty":-0.268082,"marketCap":13507988},{"date":"2024-09-13","current":-0.249238,"twenty":-13.530673,"median":-1.490506,"eighty":-0.266001,"marketCap":14194834},{"date":"2024-09-20","current":-0.251859,"twenty":-13.523184,"median":-1.447342,"eighty":-0.264233,"marketCap":14344109},{"date":"2024-09-27","current":-0.18331,"twenty":-13.517129,"median":-1.438813,"eighty":-0.263854,"marketCap":10440072},{"date":"2024-10-04","current":-0.176878,"twenty":-13.517129,"median":-1.412966,"eighty":-0.261906,"marketCap":10073753},{"date":"2024-10-11","current":-0.169642,"twenty":-13.509257,"median":-1.382811,"eighty":-0.258929,"marketCap":9661645},{"date":"2024-10-18","current":-0.172858,"twenty":-13.503584,"median":-1.362478,"eighty":-0.257477,"marketCap":9844804},{"date":"2024-10-25","current":-0.172054,"twenty":-13.503584,"median":-1.33856,"eighty":-0.254131,"marketCap":9799015},{"date":"2024-10-31","current":-0.173662,"twenty":-13.503584,"median":-1.325636,"eighty":-0.25318,"marketCap":9890594},{"date":"2024-11-08","current":-0.176878,"twenty":-13.492749,"median":-1.309578,"eighty":-0.251712,"marketCap":10073753},{"date":"2024-11-15","current":-0.18733,"twenty":-13.479205,"median":-1.300962,"eighty":-0.249749,"marketCap":10669021},{"date":"2024-11-22","current":-0.136925,"twenty":-13.476496,"median":-1.292347,"eighty":-0.248434,"marketCap":9707435},{"date":"2024-11-29","current":-0.139803,"twenty":-13.476496,"median":-1.266424,"eighty":-0.246852,"marketCap":9911473},{"date":"2024-12-06","current":-0.401286,"twenty":-13.471084,"median":-1.236345,"eighty":-0.246852,"marketCap":28449599},{"date":"2024-12-13","current":-0.361805,"twenty":-13.464762,"median":-1.214806,"eighty":-0.247049,"marketCap":25650525},{"date":"2024-12-20","current":-0.2576,"twenty":-13.462952,"median":-1.20619,"eighty":-0.247928,"marketCap":18262807},{"date":"2024-12-27","current":-0.267956,"twenty":-13.462952,"median":-1.197575,"eighty":-0.248434,"marketCap":18996990},{"date":"2025-01-03","current":-0.246597,"twenty":-13.461071,"median":-1.197575,"eighty":-0.24693,"marketCap":17482737},{"date":"2025-01-10","current":-0.252422,"twenty":-13.453549,"median":-1.184651,"eighty":-0.247168,"marketCap":17895715},{"date":"2025-01-17","current":-0.271192,"twenty":-13.435863,"median":-1.171204,"eighty":-0.246826,"marketCap":19226422},{"date":"2025-01-24","current":-0.28802,"twenty":-13.425028,"median":-1.163112,"eighty":-0.246861,"marketCap":20419470},{"date":"2025-01-31","current":-0.286078,"twenty":-12.433966,"median":-1.128649,"eighty":-0.247108,"marketCap":20281810},{"date":"2025-02-07","current":-0.280253,"twenty":-12.118971,"median":-1.102802,"eighty":-0.248181,"marketCap":19868832},{"date":"2025-02-14","current":-0.260189,"twenty":-7.581444,"median":-1.079109,"eighty":-0.248434,"marketCap":18446352},{"date":"2025-02-21","current":-0.258247,"twenty":-6.44742,"median":-1.016646,"eighty":-0.248892,"marketCap":18308693},{"date":"2025-02-28","current":-0.236888,"twenty":-6.437057,"median":-0.948463,"eighty":-0.248434,"marketCap":16794440},{"date":"2025-03-07","current":-0.235015,"twenty":-6.424102,"median":-0.910524,"eighty":-0.246734,"marketCap":16661626},{"date":"2025-03-14","current":-1.176604,"twenty":-6.415034,"median":-0.895349,"eighty":-0.246597,"marketCap":83416526},{"date":"2025-03-21","current":-1.286567,"twenty":-6.412443,"median":-0.944669,"eighty":-0.246597,"marketCap":91212464},{"date":"2025-03-28","current":-1.638241,"twenty":-6.412443,"median":-0.990799,"eighty":-0.246734,"marketCap":86482720},{"date":"2025-04-04","current":-1.477801,"twenty":-6.412443,"median":-1.079109,"eighty":-0.246852,"marketCap":78013098},{"date":"2025-04-11","current":-1.418689,"twenty":-6.412443,"median":-1.102802,"eighty":-0.247049,"marketCap":74892574},{"date":"2025-04-17","current":-1.891585,"twenty":-6.409852,"median":-1.120034,"eighty":-0.247674,"marketCap":99856765},{"date":"2025-04-25","current":-2.398963,"twenty":-6.405966,"median":-1.158804,"eighty":-0.248434,"marketCap":126641262},{"date":"2025-05-02","current":-1.600951,"twenty":-6.405966,"median":-1.171204,"eighty":-0.248476,"marketCap":84514189},{"date":"2025-05-09","current":-1.57096,"twenty":-6.405966,"median":-1.178473,"eighty":-0.248798,"marketCap":86074451},{"date":"2025-05-16","current":-1.494676,"twenty":-6.405966,"median":-1.197575,"eighty":-0.24919,"marketCap":81894776},{"date":"2025-05-23","current":-1.451835,"twenty":-6.405966,"median":-1.197575,"eighty":-0.249213,"marketCap":79547473},{"date":"2025-05-30","current":-1.480395,"twenty":-6.405966,"median":-1.20619,"eighty":-0.249269,"marketCap":81112342},{"date":"2025-06-06","current":-1.6946,"twenty":-6.405318,"median":-1.214806,"eighty":-0.249483,"marketCap":92848854}],"updateTime":1749362226648}}}